Clinigence Holdings, a technology-enabled, risk-bearing population health management company, completed a $3 million strategic equity investment from Apollo Medical Holdings.
Under terms of the investment, Clinigence issued 1 million shares to ApolloMed at $3 per share with warrants to purchase an additional 500,000 shares at $3.50 per share. Brandon Sim, COO and CTO of ApolloMed, will join Clinigence’s Board of Directors. Read more.
